Find Research outputs

Search results

• 2022

  A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs

  Hinchcliff, E., Gunther, J., Ponnie, A. E., Bednarski, B., Onstad, M., Shafer, A., Frumovitz, M., Jazaeri, A., Urbauer, D. & Bodurka, D. C., Jun 2022, In: Journal of Cancer Education. 37, 3, p. 615-620 6 p.

  Research output: Contribution to journal › Article › peer-review

• A Novel Artificial Intelligence–Powered Method for Prediction of Early Recurrence of Prostate Cancer after Prostatectomy and Cancer Drivers

  Huang, W., Randhawa, R., Jain, P., Hubbard, S., Eickhoff, J., Kummar, S., Wilding, G., Basu, H. & Roy, R., 2022, In: JCO Clinical Cancer Informatics. 6, e2100131.

  Research output: Contribution to journal › Article › peer-review

• A novel case of malignant ossifying fibromyxoid tumor with a BCOR internal tandem duplication in a child

  McEvoy, M. T., Blessing, M. M., Fisher, K. E., Paulino, A. C., Nuchtern, J., Chelius, D. C., Dimachkieh, A. L., Aldave, G. & Okcu, M. F., 2022, (Accepted/In press) In: Pediatric Blood and Cancer.

  Research output: Contribution to journal › Letter › peer-review

• A novel proton-integrating radiography system design using a monolithic scintillator detector: Experimental studies

  Darne, C. D., Robertson, D. G., Alsanea, F., Collins-Fekete, C. A. & Beddar, S., Mar 11 2022, In: Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 1027, 166077.

  Research output: Contribution to journal › Article › peer-review

• A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies

  Xu, Y., Chen, Y., Niu, Z., Xing, J., Yang, Z., Yin, X., Guo, L., Zhang, Q., Qiu, H. & Han, Y., Apr 15 2022, In: Frontiers in Medicine. 9, 841568.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• A novel simple three-level liver resection classification without compromising the performance to predict surgical and postoperative outcomes

  Kawaguchi, Y., Fuks, D., Vauthey, J. N., Kokudo, N., Gayet, B. & Hasegawa, K., Jan 2022, In: European Journal of Surgical Oncology. 48, 1, p. 305-306 2 p.

  Research output: Contribution to journal › Letter › peer-review

• An overview of the BOIN design and its current extensions for novel early-phase oncology trials

  Ananthakrishnan, R., Lin, R., He, C., Chen, Y., Li, D. & LaValley, M., Aug 2022, In: Contemporary Clinical Trials Communications. 28, 100943.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial

  Mitra, A. P., Narayan, V. M., Mokkapati, S., Miest, T., Boorjian, S. A., Alemozaffar, M., Konety, B. R., Shore, N. D., Gomella, L. G., Kamat, A. M., Bivalacqua, T. J., Montgomery, J. S., Lerner, S. P., Busby, J. E., Poch, M., Crispen, P. L., Steinberg, G. D., Schuckman, A. K., Downs, T. M., Svatek, R. S., & 25 othersMashni, J., Lane, B. R., Guzzo, T. J., Bratslavsky, G., Karsh, L. I., Woods, M. E., Brown, G. A., Canter, D., Luchey, A., Lotan, Y., Krupski, T., Inman, B. A., Williams, M. B., Cookson, M. S., Keegan, K. A., Andriole, G. L., Sankin, A. I., Boyd, A., O'Donnell, M. A., Philipson, R., Ylä-Herttuala, S., Sawutz, D., Parker, N. R., McConkey, D. J. & Dinney, C. P. N., Mar 2022, In: European urology. 81, 3, p. 223-228 6 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA

  ANSELMA collaborative group, May 2022, In: European Journal of Cancer. 166, p. 112-125 14 p.

  Research output: Contribution to journal › Review article › peer-review

• Antibiotic Prophylaxis of Surgical Site Infections-A Double-edged Sword for Oncology Patients?

  Lewis, V. O. & Roland, C. L., 2022, In: JAMA Oncology. 8, 3, p. 340-342 3 p.

  Research output: Contribution to journal › Editorial › peer-review

• Anticoagulation and bleeding in the cancer patient

  Escobar, A., Salem, A. M., Dickson, K., Johnson, T. N., Burk, K. J., Bashoura, L. & Faiz, S. A., Oct 2022, In: Supportive Care in Cancer. 30, 10, p. 8547-8557 11 p.

  Research output: Contribution to journal › Article › peer-review

• Antimicrobials and resistance part II: Antifungals, antivirals, and antiparasitics

  Muhaj, F. F., George, S. J., Nguyen, C. D. & Tyring, S. K., Jun 2022, In: Journal of the American Academy of Dermatology. 86, 6, p. 1207-1226 20 p.

  Research output: Contribution to journal › Review article › peer-review
  4 Scopus citations

• Anti-PD-L1 plus enzalutamide does not improve overall survival in prostate cancer

  Siddiqui, B. A., Subudhi, S. K. & Sharma, P., Apr 19 2022, In: Cell Reports Medicine. 3, 4, 100613.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas

  Wei, S., Yin, D., Yu, S., Lin, X., Savani, M. R., Du, K., Ku, Y., Wu, D., Li, S., Liu, H., Tian, M., Chen, Y., Bowie, M., Hariharan, S., Waitkus, M., Keir, S. T., Sugarman, E. T., Deek, R. A., Labrie, M., Khasraw, M., & 10 othersLu, Y., Mills, G. B., Herlyn, M., Wu, K., Liu, L., Wei, Z., Flaherty, K. T., Abdullah, K., Zhang, G. & Ashley, D. M., May 15 2022, In: Clinical Cancer Research. 28, 10, p. 2180-2195 16 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

  Della Corte, C. M., Fasano, M., Ciaramella, V., Cimmino, F., Cardnell, R., Gay, C. M., Ramkumar, K., Diao, L., Di Liello, R., Viscardi, G., Famiglietti, V., Ciardiello, D., Martini, G., Napolitano, S., Tuccillo, C., Troiani, T., Martinelli, E., Wang, J., Byers, L., Morgillo, F., & 1 othersCiardiello, F., Dec 2022, In: Journal of Experimental and Clinical Cancer Research. 41, 1, 109.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study

  Subbiah, V., Braña, I., Longhi, A., Boni, V., Delord, J. P., Awada, A., Boudou-Rouquette, P., Sarantopoulos, J., Shapiro, G. I., Elias, A., Ratan, R., Fernandez, C., Kahatt, C., Cullell-Young, M., Siguero, M., Zeaiter, A. & Chawla, S. P., Jul 1 2022, In: Clinical Cancer Research. 28, 13, p. 2762-2770 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• An update on cancer-related fatigue in older adults: A narrative review

  Soones, T., Ombres, R. & Escalante, C., Mar 2022, In: Journal of Geriatric Oncology. 13, 2, p. 125-131 7 p.

  Research output: Contribution to journal › Review article › peer-review
  1 Scopus citations

• A pan-cancer compendium of chromosomal instability

  Drews, R. M., Hernando, B., Tarabichi, M., Haase, K., Lesluyes, T., Smith, P. S., Morrill Gavarró, L., Couturier, D. L., Liu, L., Schneider, M., Brenton, J. D., Van Loo, P., Macintyre, G. & Markowetz, F., Jun 30 2022, In: Nature. 606, 7916, p. 976-983 8 p.

  Research output: Contribution to journal › Article › peer-review
  8 Scopus citations

• A panel of emerging EMT genes identified in malignant mesothelioma

  Wu, L., Amjad, S., Yun, H., Mani, S. & de Perrot, M., Dec 2022, In: Scientific reports. 12, 1, 1007.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  3 Scopus citations

• A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom

  Catana, C., Laforest, R., An, H., Boada, F., Cao, T., Faul, D., Jakoby, B., Jansen, F. P., Kemp, B. J., Kinahan, P. E., Larson, P., Levine, M. A., Maniawski, P., Mawlawi, O., McConathy, J. E., McMillan, A. B., Price, J. C., Rajagopal, A., Sunderland, J., Veit-Haibach, P., & 3 othersWangerin, K. A., Ying, C. & Hope, T. A., Apr 1 2022, In: Journal of Nuclear Medicine. 63, 4, p. 615-621 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC

  Piha-Paul, S., Simon, G., Belani, C. P., Chao, H., Gaspar, K., Lee, B. & Dowlati, A., Nov 2022, In: JTO Clinical and Research Reports. 3, 11, 100408.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A phase 1/2, open-label, multicenter study to investigate the safety, pharmacokinetics, and efficacy of fadraciclib (CYC065), an oral CDK2/9 inhibitor, in subjects with advanced solid tumors and lymphoma

  Piha-Paul, S., Oh, D. Y., Garralda, E., Vieito, M., Huang, J., Kirschbaum, M. & Villanona-Calero, M., Oct 2022, In: European Journal of Cancer. 174, p. S17-S18

  Research output: Contribution to journal › Article › peer-review

• A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy

  Msaouel, P., Goswami, S., Thall, P. F., Wang, X., Yuan, Y., Jonasch, E., Gao, J., Campbell, M. T., Shah, A. Y., Corn, P. G., Tam, A. L., Ahrar, K., Rao, P., Sircar, K., Cohen, L., Basu, S., Duan, F., Jindal, S., Zhang, Y., Chen, H., & 6 othersYadav, S. S., Shazer, R., Der-Torossian, H., Allison, J. P., Sharma, P. & Tannir, N. M., Apr 20 2022, In: Science translational medicine. 14, 641, eabm6420.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations

• A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer

  ETCTN-8282 study team, May 2022, In: Cancer chemotherapy and pharmacology. 89, 5, p. 721-735 15 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC

  Camidge, D. R., Barlesi, F., Goldman, J. W., Morgensztern, D., Heist, R., Vokes, E., Angevin, E., Hong, D. S., Rybkin, I. I., Barve, M., Bauer, T. M., Delmonte, A., Dunbar, M., Motwani, M., Parikh, A., Noon, E., Wu, J., Blot, V. & Kelly, K., Jan 2022, In: JTO Clinical and Research Reports. 3, 1, 100262.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors

  Harding, J. J., Garrido-Laguna, I., Chen, X., Basu, C., Dowlati, A., Forgie, A., Hooper, A. T., Kamperschroer, C., Max, S. I., Moreau, A., Shannon, M., Wong, G. Y. & Hong, D. S., Apr 14 2022, In: Frontiers in immunology. 13, 845417.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A phase 1 study of IDH305 in patients with IDH1^R132-mutant acute myeloid leukemia or myelodysplastic syndrome

  DiNardo, C. D., Hochhaus, A., Frattini, M. G., Yee, K., Zander, T., Kraemer, A., Chen, X., Ji, Y., Parikh, N. S., Choi, J. & Wei, A. H., 2022, (Accepted/In press) In: Journal of cancer research and clinical oncology.

  Research output: Contribution to journal › Article › peer-review

• A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma

  Strati, P., Coleman, M., Champion, R., Ma, S., Patti, C., Levy, M. Y., Lossos, I. S., Geethakumari, P. R., Lam, S., Calvo, R., Higgins, K. & Budde, L. E., Oct 2022, In: British Journal of Haematology. 199, 1, p. 76-85 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors

  Murphy, E. S., Dhall, G., Fangusaro, J., Bartels, U., Fouladi, M., Shaw, D., Khatua, S., Hughes, C. W., Panigraphy, A., Ioakeim-Ioannidou, M., Souweidane, M., Morris, D., Gajjar, A., Wu, S., Onar-Thomas, A., Haas-Kogan, D. A. & MacDonald, S. M., May 1 2022, In: International Journal of Radiation Oncology Biology Physics. 113, 1, p. 143-151 9 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers

  Diab, A., Hamid, O., Thompson, J. A., Ros, W., Eskens, F. A. L. M., Doi, T., Hu-Lieskovan, S., Klempner, S. J., Ganguly, B., Fleener, C., Wang, X., Joh, T., Liao, K., Salek-Ardakani, S., Taylor, C. T., Chou, J. & El-Khoueiry, A. B., Jan 1 2022, In: Clinical Cancer Research. 28, 1, p. 71-83 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  12 Scopus citations

• A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies

  Ma, W. W., Li, J. J., Azad, N. S., Lam, E. T., Diamond, J. R., Dy, G. K., Opyrchal, M., Zhi, J., Kramer, D., Chan, W. K., Cutler, D., Kwan, R., Adjei, A. A. & Jimeno, A., Jul 2022, In: Cancer chemotherapy and pharmacology. 90, 1, p. 7-17 11 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma

  Xu, Y., Dong, B., Zhu, W., Li, J., Huang, R., Sun, Z., Yang, X., Liu, L., He, H., Liao, Z., Guan, N., Kong, Y., Wang, W., Chen, J., He, H., Qiu, G., Zeng, M., Pu, J., Hu, W., Bao, Y., & 15 othersLiu, Z., Ma, J., Jiang, H., Du, X., Hu, J., Zhuang, T., Cai, J., Huang, J., Tao, H., Liu, Y., Liang, X., Zhou, J., Tao, G., Zheng, X. & Chen, M., May 1 2022, In: Clinical Cancer Research. 28, 9, p. 1792-1799 8 p.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations

• A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations

  Desikan, S. P., Ravandi, F., Pemmaraju, N., Konopleva, M., Loghavi, S., Jabbour, E. J., Daver, N., Jain, N., Chien, K. S., Maiti, A., Montalban-Bravo, G., Kadia, T. M., MacAron, W., Delumpa, R., Kwari, M., Borthakur, G. & Short, N. J., Sep 1 2022, In: Acta haematologica. 145, 5, p. 529-536 8 p.

  Research output: Contribution to journal › Article › peer-review

• A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma

  Stover, E. H., Xiong, N., Myers, A. P., Tayob, N., Engvold, V., Polak, M., Broaddus, R. R., Makker, V., Drapkin, R., Liu, J. F., Horowitz, N. S., Meric-Bernstam, F., Aghajanian, C., Coleman, R. L., Mills, G. B., Cantley, L. C., Matulonis, U. A., Westin, S. N. & Konstantinopoulos, P. A., Apr 2022, In: Gynecologic Oncology Reports. 40, 100974.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• A phase i study of ixazomib and erlotinib in patients with advanced solid tumors

  Kato, S., Adashek, J. J., Subbiah, V., Fu, S., Sun, M., Nguyen, L., Brown, E. J., Yap, T. A., Karp, D. D., Piha-Paul, S. A. & Hong, D. S., Feb 2022, In: Investigational New Drugs. 40, 1, p. 99-105 7 p.

  Research output: Contribution to journal › Article › peer-review

• A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation

  Metts, J. L., Trucco, M., Weiser, D. A., Thompson, P., Sandler, E., Smith, T., Crimella, J., Sansil, S., Thapa, R., Fridley, B. L., Llosa, N., Badgett, T., Gorlick, R., Reed, D. & Gill, J. B., 2022, (Accepted/In press) In: Cancer medicine.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A phase two study of high dose blinatumomab in Richter’s syndrome

  Thompson, P. A., Jiang, X., Banerjee, P., Basar, R., Garg, N., Chen, K., Kaplan, M., Nandivada, V., Cortes, A. K. N., Ferrajoli, A., Keating, M. J., Peterson, C. B., Andreeff, M., Rezvani, K. & Wierda, W. G., Sep 2022, In: Leukemia. 36, 9, p. 2228-2232 5 p.

  Research output: Contribution to journal › Article › peer-review

• A Photography-based, Social Media Walking Intervention Targeting Autonomous Motivations for Physical Activity: Semistructured Interviews With Older Women

  Robertson, M. C., Swartz, M. C., Christopherson, U., Bentley, J. R., Basen-Engquist, K. M., Thompson, D., Volpi, E. & Lyons, E. J., Apr 1 2022, In: JMIR Serious Games. 10, 2, e35511.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A Pilot Educational Intervention to Support Primary Care Provider Performance of Skin Cancer Examinations

  Nelson, K. C., Seiverling, E. V., Gonna, N., Berry, E., Stoos, E., Dorsey, C. N., Sepulveda, S., Vazquez, G., Doan, H. Q. & Haydu, L. E., 2022, (Accepted/In press) In: Journal of Cancer Education.

  Research output: Contribution to journal › Article › peer-review

• A pilot study: Comparison of TRPS1 and GATA3 immunoperoxidase staining using cytologic smears in entities reportedly positive for GATA3

  Rohra, P., Ding, C., Yoon, E. C. & Gan, Q., 2022, (Accepted/In press) In: Cancer Cytopathology.

  Research output: Contribution to journal › Article › peer-review

• Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study

  Westerman, M. E., Bree, K. K., Msaouel, P., Kukreja, J. B., Mantaring, C., Rukundo, I., Gonzalez, M. G., Gregg, J. R., Casteel, K. N. & Matin, S. F., Oct 1 2022, In: The Journal of Urology. 208, 4, p. 886-895 10 p.

  Research output: Contribution to journal › Article › peer-review

• Apoptosis Detection in Retinal Ganglion Cells Using Quantitative Changes in Multichannel Fluorescence Colocalization

  Qiu, X., Gammon, S. T., Johnson, J. R., Pisaneschi, F., Millward, S. W., Barnett, E. M. & Piwnica-Worms, D., Sep 2022, In: Biosensors. 12, 9, 693.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases

  Dijksterhuis, W. P. M., Kroese, T. E., Verhoeven, R. H. A., van Rossum, P. S. N., Mook, S., Haj Mohammad, N., Hulshof, M. C. C. M., Gisbertz, S. S., Ruurda, J. P., van Oijen, M. G. H., van Hillegersberg, R. & van Laarhoven, H. W. M., Sep 2022, In: European Journal of Surgical Oncology. 48, 9, p. 1964-1971 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• Applicant's Perspective: Identifying a Program Through Virtual Interviewing

  Nelson, D. B. & Antonoff, M. B., Jul 2022, In: Annals of Thoracic Surgery. 114, 1, p. 356-357 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study

  Murakami, K., Kamat, A. M., Dai, Y., Pagano, I., Chen, R., Sun, Y., Gupta, A., Goodison, S., Rosser, C. J. & Furuya, H., 2022, In: Cancer Biomarkers. 33, 1, p. 151-157 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

  Irajizad, E., Wu, R., Vykoukal, J. V., Murage, E., Spencer, R., Dennison, J. B., Moulder, S., Ravenberg, E., Lim, B., Litton, J., Tripathym, D., Valero, V., Damodaran, S., Rauch, G. M., Adrada, B., Candelaria, R., White, J. B., Brewster, A., Arun, B., Long, J. P., & 3 othersDo, K-A., Hanash, S. & Fahrmann, J. F., Aug 11 2022, In: Frontiers in Artificial Intelligence. 5, 876100.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Application of Deep Learning to Ischemic and Hemorrhagic Stroke Computed Tomography and Magnetic Resonance Imaging

  Zhu, G., Chen, H., Jiang, B., Chen, F., Xie, Y. & Wintermark, M., Apr 2022, In: Seminars in Ultrasound, CT and MRI. 43, 2, p. 147-152 6 p.

  Research output: Contribution to journal › Article › peer-review

• Application of precision medicine in clinical routine in haematology—Challenges and opportunities

  Wästerlid, T., Cavelier, L., Haferlach, C., Konopleva, M., Fröhling, S., Östling, P., Bullinger, L., Fioretos, T. & Smedby, K. E., Aug 2022, In: Journal of Internal Medicine. 292, 2, p. 243-261 19 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development

  Yap, T. A., Jacobs, I., Baumfeld Andre, E., Lee, L. J., Beaupre, D. & Azoulay, L., Jan 6 2022, In: Frontiers in Oncology. 11, 695936.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers

  Addanki, S., Meas, S., Sarli, V. N., Singh, B. & Lucci, A., Jul 2022, In: International journal of molecular sciences. 23, 14, 7843.

  Research output: Contribution to journal › Review article › peer-review

  Open Access
  1 Scopus citations